Bank of New York Mellon’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$878K Sell
31,739
-90,120
-74% -$2.49M ﹤0.01% 3185
2025
Q1
$2.71M Sell
121,859
-192
-0.2% -$4.26K ﹤0.01% 2530
2024
Q4
$2.41M Buy
122,051
+30,382
+33% +$601K ﹤0.01% 2665
2024
Q3
$2.29M Sell
91,669
-23,474
-20% -$587K ﹤0.01% 2685
2024
Q2
$2.15M Buy
115,143
+2,563
+2% +$47.9K ﹤0.01% 2756
2024
Q1
$2.22M Sell
112,580
-20,973
-16% -$414K ﹤0.01% 2709
2023
Q4
$2.34M Sell
133,553
-13,015
-9% -$228K ﹤0.01% 2744
2023
Q3
$2.55M Buy
146,568
+17,790
+14% +$309K ﹤0.01% 2675
2023
Q2
$1.81M Buy
128,778
+828
+0.6% +$11.7K ﹤0.01% 2895
2023
Q1
$1.38M Buy
127,950
+603
+0.5% +$6.49K ﹤0.01% 2998
2022
Q4
$1.91M Buy
127,347
+1,819
+1% +$27.2K ﹤0.01% 2877
2022
Q3
$1.61M Buy
125,528
+4,891
+4% +$62.8K ﹤0.01% 2971
2022
Q2
$1.17M Sell
120,637
-16,364
-12% -$159K ﹤0.01% 3134
2022
Q1
$1.36M Buy
137,001
+3,095
+2% +$30.8K ﹤0.01% 3128
2021
Q4
$1.58M Sell
133,906
-1,091
-0.8% -$12.8K ﹤0.01% 3133
2021
Q3
$1.54M Buy
134,997
+3,638
+3% +$41.4K ﹤0.01% 3155
2021
Q2
$1.83M Sell
131,359
-3,056
-2% -$42.6K ﹤0.01% 3037
2021
Q1
$2.49M Sell
134,415
-2,448
-2% -$45.3K ﹤0.01% 2799
2020
Q4
$2.42M Buy
136,863
+45,909
+50% +$811K ﹤0.01% 2732
2020
Q3
$1.39M Buy
90,954
+13,437
+17% +$206K ﹤0.01% 2906
2020
Q2
$1.98M Buy
77,517
+29,295
+61% +$746K ﹤0.01% 2688
2020
Q1
$747K Buy
48,222
+1,998
+4% +$31K ﹤0.01% 3160
2019
Q4
$512K Sell
46,224
-5,989
-11% -$66.3K ﹤0.01% 3582
2019
Q3
$445K Sell
52,213
-4,158
-7% -$35.4K ﹤0.01% 3591
2019
Q2
$764K Buy
56,371
+9,427
+20% +$128K ﹤0.01% 3373
2019
Q1
$848K Buy
46,944
+26,374
+128% +$476K ﹤0.01% 3285
2018
Q4
$578K Buy
20,570
+3,499
+20% +$98.3K ﹤0.01% 3408
2018
Q3
$435K Buy
+17,071
New +$435K ﹤0.01% 3702